Edward H. Stratemeier
Direttore/Membro del Consiglio presso Igxbio, Inc.
Profilo
Edward H.
Stratemeier is currently a Director at Igxbio, Inc. He previously worked as Secretary, SVP-Legal Affairs & General Counsel at NPS Pharmaceuticals, Inc. from 2011 to 2014 and as Senior Vice President-Legal & Government Relations at Aventis Pharmaceuticals, Inc. He holds an MBA from Rockhurst University, an undergraduate degree from the University of Kansas, and a graduate degree from the University of Missouri-Kansas City.
Posizioni attive di Edward H. Stratemeier
Società | Posizione | Inizio |
---|---|---|
Igxbio, Inc.
Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Direttore/Membro del Consiglio | 30/03/2009 |
Precedenti posizioni note di Edward H. Stratemeier
Società | Posizione | Fine |
---|---|---|
NPS PHARMACEUTICALS, INC. | Consigliere Generale | 28/02/2014 |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Consigliere Generale | - |
Formazione di Edward H. Stratemeier
University of Missouri-Kansas City | Graduate Degree |
Rockhurst University | Masters Business Admin |
University of Kansas | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Igxbio, Inc.
Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
- Borsa valori
- Insiders
- Edward H. Stratemeier